Neointimal hyperplasia in allogeneic and autologous venous grafts is not different in nature

Histochemistry and Cell Biology

Volumn 144, Issue 1, 2015, Pages 59-66

  Albert, Busch ^a   Elena, Hartmann ^b   Nicole, Wagner ^b   Süleyman, Ergün ^b   Ralph, Kickuth ^b   Richard, Kellersmann ^a   Udo, Lorenz ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Angiogenesis; Bypass stenosis; Chronic limb ischemia; Cryopreserved vein; Neointimal hyperplasia

Indexed keywords

CD34 ANTIGEN;

ALLOGENEIC VENOUS GRAFT; ALLOGRAFT; ANGIOGENESIS; ARTICLE; AUTOLOGOUS VENOUS GRAFT; BLOOD VESSEL; CELL DEDIFFERENTIATION; CELL STRUCTURE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CRYOPRESERVATION; ENDOTHELIUM CELL; FIBROSIS; GRAFT OCCLUSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERPLASIA; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MONOCYTE; NEOINTIMA; NEOINTIMAL HYPERPLASIA; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; VASCULAR SMOOTH MUSCLE CELL; VEIN GRAFT; VEIN PROSTHESIS; AUTOGRAFT; COMPARATIVE STUDY; IMMUNOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SAPHENOUS VEIN; TRANSPLANTATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ALLOGRAFTS; AUTOGRAFTS; CRYOPRESERVATION; ENDOTHELIUM, VASCULAR; HUMANS; HYPERPLASIA; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; NEOVASCULARIZATION, PATHOLOGIC; SAPHENOUS VEIN;

EID: 84931566973     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-015-1317-3     Document Type: Article

References (40)

1. Barshes NR, Ozaki CK, Kougias P, Belkin M (2013) A cost-effectiveness analysis of infrainguinal bypass in the absence of great saphenous vein conduit. J Vasc Surg 57:1466–1470. doi:10.1016/j.jvs.2012.11.115
2. Bia D, Zocalo Y, Pessana F, Armentano R, Perez H, Saldias M, Alvarez I (2007) Differential functional coupling between human saphenous cryoallografts and arteries: importance of the arterial type and the biomechanical parameter evaluated. Artif Organs 31:809–818. doi:10.1111/j.1525-1594.2007.00467.x
3. Bol M et al (2013) Inhibiting connexin channels protects against cryopreservation-induced cell death in human blood vessels. Eur J Vasc Endovasc Surg 45:382–390. doi:10.1016/j.ejvs.2012.12.012
4. Carpenter JP, Tomaszewski JE (1998) Human saphenous vein allograft bypass grafts: immune response. J Vasc Surg 27:492–499
5. Collins MJ et al (2012) Therapeutic strategies to combat neointimal hyperplasia in vascular grafts. Expert Rev Cardiovasc Ther 10:635–647. doi:10.1586/erc.12.33
6. Conte MS (2009) Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes? Semin Vasc Surg 22:227–233. doi:10.1053/j.semvascsurg.2009.10.004
7. Conte MS (2010) Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. J Vasc Surg 52:96S–103S. doi:10.1016/j.jvs.2010.06.015
8. Damrauer SM et al (2010) A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization. Atherosclerosis 211:404–408. doi:10.1016/j.atherosclerosis.2010.03.029
9. Davies MG, Hagen PO (2011) Reprinted article pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 42(Suppl. 1):S19–S29. doi:10.1016/j.ejvs.2011.06.013
10. Faggioli G, Ricotta JJ (1994) Cryopreserved vein homografts for arterial reconstruction. Eur J Vasc Surg 8:661–669
11. Fahner PJ, Idu MM, van Gulik TM, Legemate DA (2006) Systematic review of preservation methods and clinical outcome of infrainguinal vascular allografts. J Vasc Surg 44:518–524. doi:10.1016/j.jvs.2006.05.037
12. Farber A, Major K, Wagner WH, Cohen JL, Cossman DV, Lauterbach SR, Levin PM (2003) Cryopreserved saphenous vein allografts in infrainguinal revascularization: analysis of 240 grafts. J Vasc Surg 38:15–21
13. Giannoukas AD, Labropoulos N, Stavridis G, Bailey D, Glenville B, Nicolaides AN (1997) Pre-bypass quality assessment of the long saphenous vein wall with ultrasound and histology. Eur J Vasc Endovasc Surg 14:37–40
14. Harris L, O’Brien-Irr M, Ricotta JJ (2001) Long-term assessment of cryopreserved vein bypass grafting success. J Vasc Surg 33:528–532. doi:10.1067/mva.2001.111729
15. Johnson TR, Tomaszewski JE, Carpenter JP (2000) Cellular repopulation of human vein allograft bypass grafts. J Vasc Surg 31:994–1002. doi:10.1067/mva.2000.105676
16. Khurana R, Simons M, Martin JF, Zachary IC (2005) Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112:1813–1824. doi:10.1161/CIRCULATIONAHA.105.535294
17. Kohler TR, Kirkman TR, Clowes AW (1989) The effect of rigid external support on vein graft adaptation to the arterial circulation. J Vasc Surg 9:277–285
18. Kreienberg P, Cheema M, Chang BB, Paty PS, Roddy SP, Darling RC III (2007) Primary revision of mid-vein stenoses in venous bypass conduits: venous patch versus interposition vein. J Vasc Surg 45:929–934; discussion 934–935. doi:10.1016/j.jvs.2007.01.018
19. Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB (2012) The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 95:194–204. doi:10.1093/cvr/cvs135
20. Leseche G, Penna C, Bouttier S, Joubert S, Andreassian B (1997) Femorodistal bypass using cryopreserved venous allografts for limb salvage. Ann Vasc Surg 11:230–236
21. Luo Z, Asahara T, Tsurumi Y, Isner JM, Symes JF (1998) Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J Vasc Surg 27:167–173
22. Malinska A, Perek B, Buczkowski P, Kowalska K, Ostalska-Nowicka D, Witkiewicz W, Nowicki M (2013) CD68 expression in aortocoronary saphenous vein bypass grafts. Histochem Cell Biol 140:183–188. doi:10.1007/s00418-012-1069-2
23. Martin RS III, Edwards WH, Mulherin JL Jr, Edwards WH Jr, Jenkins JM, Hoff SJ (1994) Cryopreserved saphenous vein allografts for below-knee lower extremity revascularization. Ann Surg 219:664–670; discussion 670–672
24. Miller VM, Bergman RT, Gloviczki P, Brockbank KG (1993) Cryopreserved venous allografts: effects of immunosuppression and antiplatelet therapy on patency and function. J Vasc Surg 18:216–226
25. Mitra AK, Gangahar DM, Agrawal DK (2006) Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol 84:115–124. doi:10.1111/j.1440-1711.2005.01407.x
26. Muller-Schweinitzer E, Striffeler H, Grussenmeyer T, Reineke DC, Glusa E, Grapow MT (2007) Impact of freezing/thawing procedures on the post-thaw viability of cryopreserved human saphenous vein conduits. Cryobiology 54:99–105. doi:10.1016/j.cryobiol.2006.11.006
27. Murphy GJ et al (2007) Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts. Cardiovasc Res 73:607–617. doi:10.1016/j.cardiores.2006.11.015
28. Muto A, Model L, Ziegler K, Eghbalieh SD, Dardik A (2010) Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. Circ J Off J Jpn Circ Soc 74:1501–1512
29. Pusztaszeri MP, Seelentag W, Bosman FT (2006) Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385–395. doi:10.1369/jhc.4A6514.2005
30. Randon C, Jacobs B, De Ryck F, Beele H, Vermassen F (2010) Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage. J Vascu Surg 51:869–877. doi:10.1016/j.jvs.2009.11.062
31. Santo VJ, Dargon PT, Azarbal AF, Liem TK, Mitchell EL, Moneta GL, Landry GJ (2013) Open versus endoscopic great saphenous vein harvest for lower extremity revascularization of critical limb ischemia. J Vasc Surg. doi:10.1016/j.jvs.2013.08.007
32. Schober A, Weber C (2005) Mechanisms of monocyte recruitment in vascular repair after injury. Antioxid Redox Signal 7:1249–1257. doi:10.1089/ars.2005.7.1249
33. Shukla N, Jeremy JY (2012) Pathophysiology of saphenous vein graft failure: a brief overview of interventions. Curr Opin Pharmacol 12:114–120. doi:10.1016/j.coph.2012.01.001
34. Solanes N et al (2004) Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy. Transpl Proc 36:3288–3294. doi:10.1016/j.transproceed.2004.10.053
35. Walker PJ, Mitchell RS, McFadden PM, James DR, Mehigan JT (1993) Early experience with cryopreserved saphenous vein allografts as a conduit for complex limb-salvage procedures. J Vasc Surg 18:561–568; discussion 568–569
36. Westerband A, Gentile AT, Hunter GC, Gooden MA, Aguirre ML, Berman SS, Mills JL (2000) Intimal growth and neovascularization in human stenotic vein grafts. J Am Coll Surg 191:264–271
37. Wiedemann D, Kocher A, Bonaros N, Semsroth S, Laufer G, Grimm M, Schachner T (2012) Perivascular administration of drugs and genes as a means of reducing vein graft failure. Curr Opin Pharmacol 12:203–216. doi:10.1016/j.coph.2012.02.012
38. Zehr BP, Niblick CJ, Downey H, Ladowski JS (2011) Limb salvage with CryoVein cadaver saphenous vein allografts used for peripheral arterial bypass: role of blood compatibility. Ann Vasc Surg 25:177–181. doi:10.1016/j.avsg.2010.07.020
39. Zhang L, Hagen PO, Kisslo J, Peppel K, Freedman NJ (2002) Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model. J Vasc Surg 36:824–832
40. Zilla P et al (2012) Remodeling leads to distinctly more intimal hyperplasia in coronary than in infrainguinal vein grafts. J Vasc Surg 55:1734–1741. doi:10.1016/j.jvs.2011.11.057